The effect of carbohydrate counting on metabolic control in patients with type 1 diabetes mellitus;Tip 1 diyabetli hastalarda karbonhidrat sayiminin metabolik kontrol üzerine etkisi

Gulhane Medical Journal

Volumn 51, Issue 1, 2009, Pages 1-5

  Abaci, Ayhan ^a   Ataş, Ali ^a   Ünüvar, Tolga ^a   Böber, Ece ^a   Büyükgebiz, Atilla ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Carbohydrate counting; Type 1 diabetes mellitus

Indexed keywords

EID: 69349090809     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gillespie SJ, Kulkarni KD, Daly AE. Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 1998; 98: 897-905.
2. Kulkarni KD. Carbohydrate counting: a practical mealplanning option for people with diabetes. Clinical Diabetes 2005; 23: 120-122.
3. Johnson M. Carbohydrate counting for people with type 2 diabetes. Diabetes Spectrum 2000; 13: 149.
4. Hirsch IB. Type 1 diabetes mellitus and the use of flexible insulin regimens. Am Fam Physician 1999; 60: 2343-2346.
5. Otabe S, Yamada K, Takane N, Inada C, Iwasaki S, Nonaka K. Effects of the carbohydrate composition of a low-protein meal on the postprandial responses of plasma glucose and insulin in diabetic patients. Intern Med 1993; 32: 629-632.
6. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003; 26: S51-S61.
7. National Center for Health Statistics-CDC Growth Charts: United States, 2002 [article online]. Available from http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/datafiles.htm (Last accessed: May 16, 2008)
8. Lorini R, Ciriaco O, Salvatoni A, Livieri C, Larizza D, D'Annunzio G. The influence of dietary education in diabetic children. Diabetes Res Clin Pract 1990; 9: 279-285.
9. American Diabetes Association Task Force for Writing Nutrition Principles and Recommendations for the Management of Diabetes and Related Complications. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25: 202-212.
10. Connell JE, Thomas-Dobersen D. Nutritional management of children and adolescents with insulin-dependent diabetes mellitus: a review by the diabetes care and education dietetic practice group. J Am Diet Assoc 1991; 91: 1556-1564.
11. Waldron S, Hanas R, Palmvig B. How do we educate young people to balance carbohydrate intake with adjustments of insulin? Horm Res 2002; 57: 62-65.
12. Alemzadeh R, Palma-Sisto P, Parton E, Totka J, Kirby M. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. Acta Diabetol 2003; 40: 137-142.
13. Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004; 114: e91-e95.
14. Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003; 112: 559-564.
15. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003; 143: 796-801.
16. The DCCT Research Group. Weight gain associated with intensive therapy in the diabetes control and complications trial. Diabetes Care 1988; 11: 567-573.
17. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90: 450-459.
18. Nordfeldt S, Ludvigsson J. Severe hypoglycemia in children with IDDM. A prospective population study, 1992-1994. Diabetes Care 1997; 20: 497-503.
19. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000; 23: 1232-1235.
20. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care [1996;] 19: 324-327.
21. Eichner HL, Selam JL, Holleman CB, Worcester BR, Turner DS, Charles MA. Reduction of severe hypoglycemic events in type I (insulin dependent) diabetic patients using continuous subcutaneous insulin infusion. Diabetes Res 1988; 8: 189-193.
22. Porcellati F, Rossetti P, Pampanelli S, et al. Better longterm glycaemic control with the basal insulin glargine as compared with NPH in patients with type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med 2004; 21: 1213-1220.
23. Ratner R. Insulin glargine versus NPH insulin in patients with type 1 diabetes. Drugs Today (Barc) 2003; 39: 867-876.
24. Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002; 140: 235-240.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
26. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-389.